Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Karl Semaan, M.D.

Concepts (47)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Karl Semaan's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Karl Semaan has written about over time.
Postural Balance, 1 publications between 2022 and 2022, average publication date March 2022. Gait, 2 publications between 2022 and 2022, average publication date June 2022. Kyphosis, 1 publications between 2022 and 2022, average publication date August 2022. Walking, 2 publications between 2022 and 2024, average publication date February 2023. Spine, 4 publications between 2022 and 2024, average publication date March 2023. Arthroplasty, Replacement, Hip, 1 publications between 2023 and 2023, average publication date December 2023. Osteoarthritis, Hip, 1 publications between 2023 and 2023, average publication date December 2023. Epigenomics, 3 publications between 2023 and 2024, average publication date April 2024. Carcinoma, Renal Cell, 4 publications between 2023 and 2024, average publication date April 2024. Kidney Neoplasms, 4 publications between 2023 and 2024, average publication date April 2024. Immunohistochemistry, 1 publications between 2024 and 2024, average publication date May 2024. In Situ Hybridization, Fluorescence, 1 publications between 2024 and 2024, average publication date May 2024. Receptor, ErbB-2, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Semaan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (47)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.